Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ReadyRx vs RxPepsDirect

ReadyRx
Graded #168

Lower grade

vs+1.1000000000000085
RxPepsDirect
Graded #146

Higher grade

The verdict

RxPepsDirect takes it — 68.7/100 to 67.6/100, but only just.

RxPepsDirect grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxPepsDirect (Peptide RX LLC) is a per-vial compounded GLP-1 telehealth platform offering semaglutide/B12 from $25/vial and tirzepatide/B12 from $45/vial, dispensed through Optimal Balance Pharmacy (503A,… ReadyRx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxPepsDirect +14
60
74
Dose & formulationEven
64
64
Clinical oversightReadyRx +10
79
69
Labs & monitoringRxPepsDirect +8
64
72
FulfillmentReadyRx +13
83
70
Contract termsEven
55
55
ReadyRx · left barRxPepsDirect · right bar

The numbers

MetricReadyRxRxPepsDirect
WeighScore67.6/10068.7/100
GradeCC
Scorecard rank#168#146
Semaglutide$179/mo (starting dose, compounded)$64/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$255/mo (starting dose, compounded)$84/mo (starting dose, plus a separate fee, compounded)
CoverageAll 50 states28 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
ReadyRx

Graded #168 · C

Strengths

  • LegitScript Certified — verifiable via the badge link in the footer
  • Batch lab testing covers the right QA metrics for injectables: potency, sterility, pH, and endotoxicity
  • Pricing shown publicly: $179/mo semaglutide, $255/mo tirzepatide

Where it loses points

  • Pharmacy partners not named — only described as 'FDA-registered compounding pharmacies'
  • Clinicians described as licensed and board-certified, but no names or credentials published
  • 5,000+ member figure comes from a directory listing, not an independent audit
RxPepsDirect

Graded #146 · C

Strengths

  • Industry-lowest GLP-1 pricing: compounded semaglutide from $25/vial, tirzepatide from $45/vial — no subscription or recurring commitment required
  • Real 503A telehealth Rx: licensed NP/PA prescribers + MD medical director (Dr. Jonathan Snipes, NPI 1821250077); patient-specific Rx dispensed by
  • FedEx overnight shipping at $15 flat; ships pre-reconstituted and includes syringes, alcohol wipes, and reusable cooled travel case
  • Independent batch COA testing by Eagle Analytical (FDA-registered, A2LA ISO 17025): 54/54 sterility and endotoxin passes published publicly on
  • No subscription required; $39 flat visit fee covers up to 3 peptides per Rx; pay per vial with no ongoing commitment

Where it loses points

  • No LegitScript certification; company founded 2026 — no public track record or long-term patient-outcomes data
  • Minimal clinical oversight: $39 asynchronous intake form only — no live video consult required, no labs mandated, no monitoring protocol; lowest
  • Per-vial pricing makes true monthly cost opaque; every refill costs another $39 visit fee on top of vial price and $15 shipping
  • Only 28 states + DC; excludes California, most of the Southeast (AL, AR, GA, MS, NC, SC, TN, VA), and parts of Midwest
  • No coaching, labs, dietitian support, or clinical monitoring included at any tier — purely prescription + dispensing

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard